Glutathione is the most abundant antioxidant in the human body, present in every cell, synthesized from three amino acids the body already makes, and central to nearly every detoxification pathway the liver runs. Levels decline with age. Levels drop in response to alcohol, stress, illness, environmental toxins, and intense physical exertion. The question patients and clinicians ask is whether supplementation matters, and if it does, what form actually works.
This is a primer on what glutathione is, what the evidence supports, why oral supplements largely don't work, and how the injectable protocols compare.
What it is
Glutathione is a tripeptide. It is composed of three amino acids linked together: cysteine, glutamic acid, and glycine. The cysteine residue carries the thiol (sulfhydryl, -SH) group that does most of the chemical work. The thiol group is what neutralizes free radicals, reduces oxidized molecules, and forms conjugates with toxins to escort them out of cells. When glutathione has done its job, the thiol has been oxidized to a disulfide, and the molecule is reactivated by a specific reductase enzyme that runs constantly.
The body synthesizes glutathione primarily in the liver, but every cell has the machinery to make it. The rate-limiting step is the availability of cysteine, which is the least abundant of the three amino acids in typical diets. Cysteine is also the only one that has to be supplied (glutamic acid and glycine can be produced from other amino acids more readily).
What it actually does
Glutathione operates at the intersection of several systems. The clinically relevant ones:
- Direct antioxidant. Reactive oxygen species (free radicals, peroxides) are produced as a byproduct of normal mitochondrial energy production. Without a counterbalance, they damage proteins, lipids, and DNA. Glutathione is the body's most abundant counterbalance, neutralizing these species before they cause harm.
- Phase II detoxification. The liver processes toxins (drugs, environmental chemicals, metabolic waste) in two phases. Phase I makes them more reactive; Phase II conjugates the reactive intermediates with molecules like glutathione to make them water-soluble and excretable. Without adequate glutathione, Phase II bottlenecks and the reactive Phase I intermediates accumulate.
- Regeneration of other antioxidants. Vitamins C and E and alpha-lipoic acid are recycled from their oxidized forms by glutathione. The antioxidant network is more interconnected than the marketing of individual antioxidants suggests; glutathione is the molecule that holds the network together.
- Immune function. Lymphocytes require adequate intracellular glutathione to mount a robust response. Glutathione depletion is associated with impaired immune function in older adults and patients with chronic disease.
- Protein folding and cellular signaling. Many enzymes have cysteine residues whose oxidation state determines whether they're active or inactive. The cellular glutathione pool sets the redox tone that governs these switches.
The age and lifestyle decline
Tissue glutathione concentrations decline with age in essentially every system that has been studied. The decline is most pronounced after age 40 and accelerates in the seventh and eighth decades. Erythrocyte glutathione (a commonly measured surrogate) drops by roughly 30 to 40 percent between young adulthood and old age. Whether this is causal in the diseases of aging or a downstream consequence of them is debated, but the correlation is robust.
Several common exposures deplete glutathione acutely:
- Alcohol. Ethanol metabolism produces acetaldehyde, which is conjugated and detoxified using glutathione. Heavy drinking can transiently drop hepatic glutathione substantially.
- Acetaminophen. The reason acetaminophen overdose is dangerous is that its reactive metabolite is detoxified by glutathione conjugation. Once the glutathione is exhausted, hepatocyte death follows. N-acetylcysteine, the standard antidote, works by restoring glutathione.
- Smoking and air pollution. Reactive species in tobacco smoke and combustion-source pollutants are detoxified through glutathione pathways.
- Chronic illness. Inflammation, infection, and chronic disease (especially metabolic and liver disease) all draw heavily on glutathione reserves.
- Intense exercise. Transient drops in glutathione are part of normal exercise adaptation; this is one mechanism by which training upregulates endogenous antioxidant capacity over time.
What the clinical evidence supports
The evidence base on glutathione supplementation is uneven. The strongest data is in liver disease and in specific toxicology contexts. The newer wellness-medicine indications are supported more by mechanism and small studies than by large randomized trials.
Liver disease
A 2025 literature review published in Biomedicines analyzed three trials (109 participants total) examining glutathione therapy in non-alcoholic fatty liver disease. The pooled findings showed consistent reductions in alanine transaminase (ALT) levels and in oxidative stress markers like 8-hydroxy-2-deoxyguanosine. The reviewers noted that the sample sizes were small and protocols varied, but the direction of effect was consistent across studies. Glutathione's role in hepatic detoxification provides a clear mechanistic basis for benefit in fatty liver disease.
Neurodegenerative conditions
Glutathione depletion in the substantia nigra is one of the early observable changes in Parkinson's disease, and several small trials have tested intravenous and intranasal glutathione for symptom improvement. Results have been mixed. The mechanism is plausible, but reliable, large-scale evidence of clinical benefit has not been established.
Cisplatin neurotoxicity
Glutathione infusion has been studied as a protective measure during cisplatin chemotherapy and showed reduced incidence of cisplatin-induced peripheral neuropathy in early trials. This is an oncology-specific indication and not directly relevant to wellness use.
General antioxidant and immune support
This is where most of the marketing lives and where the evidence is weakest. There are mechanistic arguments and small case-series-level data suggesting that glutathione supplementation may support immune function and reduce systemic oxidative stress, but large randomized trials in otherwise healthy adults do not exist.
Why oral glutathione largely doesn't work
Glutathione is a tripeptide. Like other peptides, it is broken down by gastric and pancreatic peptidases into its constituent amino acids before it reaches the systemic circulation. A 2014 study cited in subsequent reviews demonstrated that oral administration of glutathione did not raise levels of intact glutathione in the deproteinized fraction of blood. The orally administered molecule appears to function as a source of cysteine, glutamic acid, and glycine rather than as a delivered antioxidant.
This is the key reason injectable and other non-oral delivery routes exist. Three workarounds:
- Liposomal oral glutathione. Encapsulating glutathione in a phospholipid bilayer can protect a fraction of the dose from gastric breakdown. Bioavailability is higher than free oral glutathione but still well below injection.
- Sublingual glutathione. Absorption across the oral mucosa bypasses first-pass hepatic metabolism but the total surface area is small.
- Precursor supplementation. N-acetylcysteine (NAC) is well-absorbed orally and is converted to cysteine, which is then incorporated into glutathione synthesis. This is the strategy that powers the standard medical use of NAC for acetaminophen overdose.
What about subcutaneous, intramuscular, and intravenous?
Injection delivers intact glutathione directly to the systemic circulation, bypassing the gut entirely. Common protocols:
- Subcutaneous: 100-200 mg one to two times weekly. The format CLYR offers, and a reasonable middle ground between convenience and bioavailability. Patients self-administer at home using small-gauge insulin-style syringes.
- Intramuscular: 200 mg one to two times weekly. Higher peak levels than subcutaneous; same molecule, slightly different pharmacokinetics.
- Intravenous: 500-2000 mg per infusion, weekly or as part of a chelation/wellness protocol. Highest bioavailability but requires a clinic setting and trained personnel. More common in functional medicine and integrative oncology than in standard practice.
Safety
Glutathione is well-tolerated in most patients. The most commonly reported side effects are injection site reactions, transient flushing, and occasional gastrointestinal complaints. Allergic reactions are rare but possible.
One area where the FDA has issued warnings is the use of intravenous glutathione for skin lightening. This is a separate, cosmetic indication that has been heavily marketed in some markets (particularly internationally) but is not supported by safety data for the doses used in those protocols. The FDA's position is that compounded IV glutathione marketed for skin whitening is outside the legitimate compounding scope and that quality control in this niche has been inconsistent. The medical use of glutathione for hepatic and oxidative-stress indications is a different conversation.
Reasonable monitoring on a maintenance protocol includes periodic liver function tests, a complete blood count, and a metabolic panel. Patients with sulfa allergies should be evaluated carefully, although true cross-reactivity is uncommon.
Who is a reasonable candidate
- Adults with elevated oxidative stress from age, lifestyle, or specific exposures (heavy alcohol use, environmental toxin exposure, intense training loads) who haven't responded adequately to dietary and lifestyle interventions.
- Patients with non-alcoholic fatty liver disease pursuing adjunctive antioxidant support under physician supervision.
- Patients seeking general immune and antioxidant optimization as part of a broader wellness protocol that includes the foundational interventions (sleep, exercise, diet) that matter more than any peptide.
Who should think carefully
- Patients pursuing glutathione for skin lightening should understand that this is an FDA-flagged use that is not supported by safety data at the doses commonly used in that context.
- Patients with active sulfa allergy or known reaction to glutathione preparations.
- Pregnant or breastfeeding patients; data is limited.
- Patients expecting glutathione to do the work that diet, sleep, and exercise should be doing.
The Bottom Line
Glutathione is a real molecule that does real work in every cell of the body. It declines with age, depletes with stress and toxin exposure, and is one of several reasonable supplementation candidates in patients with elevated oxidative stress or specific liver indications. Oral supplements are largely degraded before they reach circulation; injectable protocols deliver intact molecules and produce measurable changes in tissue glutathione levels. The evidence is strongest for liver disease and weakest for the most heavily marketed wellness indications, but the safety profile is favorable and the mechanism is well-established.
As with any peptide therapy, the foundational interventions (sleep, diet, exercise, alcohol moderation, smoking cessation) move oxidative stress more than any supplement can. Glutathione is best understood as an adjunct, not a replacement, for the work that actually drives health.